FR2265406A1 - Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins - Google Patents

Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins

Info

Publication number
FR2265406A1
FR2265406A1 FR7509251A FR7509251A FR2265406A1 FR 2265406 A1 FR2265406 A1 FR 2265406A1 FR 7509251 A FR7509251 A FR 7509251A FR 7509251 A FR7509251 A FR 7509251A FR 2265406 A1 FR2265406 A1 FR 2265406A1
Authority
FR
France
Prior art keywords
hepatitis
vaccine
globulins
alumin
australian type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7509251A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Serum Institut GmbH
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Publication of FR2265406A1 publication Critical patent/FR2265406A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7509251A 1974-03-30 1975-03-25 Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins Pending FR2265406A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2415604A DE2415604A1 (de) 1974-03-30 1974-03-30 Impfstoff

Publications (1)

Publication Number Publication Date
FR2265406A1 true FR2265406A1 (en) 1975-10-24

Family

ID=5911758

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7509251A Pending FR2265406A1 (en) 1974-03-30 1975-03-25 Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins

Country Status (6)

Country Link
BE (1) BE827145A (2)
DE (1) DE2415604A1 (2)
DK (1) DK110575A (2)
FR (1) FR2265406A1 (2)
LU (1) LU71976A1 (2)
NL (1) NL7502660A (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130039943A1 (en) * 2010-05-03 2013-02-14 Bruno Rene Andre Novel method

Also Published As

Publication number Publication date
LU71976A1 (2) 1975-08-20
NL7502660A (nl) 1975-10-02
BE827145A (fr) 1975-07-16
DK110575A (2) 1975-10-01
DE2415604A1 (de) 1975-10-02

Similar Documents

Publication Publication Date Title
RU94046145A (ru) Комбинированные вакцины, содержащие поверхностный антиген гепатита в и другие антигены, способ их получения, способ предупреждения инфекций гепатита в
ES2179105T3 (es) Adyuvantes proteinicos.
EP0330359A3 (en) Composition useful in the diagnosis and treating of hiv-1 infection
Resti et al. Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
HUT38841A (en) Process for producing compositions for producing immune-response against tumours and virus
DE3380053D1 (en) Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them
ES450208A1 (es) Un metodo de preparacion de una gamma-globulina anti-hbs a partir de plasma humano.
ES8505820A1 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
FR2265406A1 (en) Hepatitis B vaccine - contains Australian type serum hepatitis antigens in an immunogenic form, alumin and globulins
GB960850A (en) Measles virus vaccine
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
JPS6456621A (en) Aluminum hydroxide gel-added hepatitis b vaccine and preparation
GB941019A (en) Improvements in and relating to the stability of anti-haemophilic globulin (factor viii)
SE7910089L (sv) Vacciner
EP0339668A3 (en) Hepatitis a virus antigen
ATE18007T1 (de) Hepatitisimpfstoff.
ES357848A1 (es) Procedimiento mejorado para la preparacion de una vacuna contra la poliomielitis.
ES466758A1 (es) Un procedimiento de preparacion de un virus sincitial respi-ratorio atenuado.
FURUHATA et al. A family study of the so-called blood group chimera
ES268958A1 (es) Procedimiento para la obtenciën de vacunas
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
DE3650590D1 (de) Verwendung von Tergurid zur Herstellung eines Arzneimittels zur Behandlung geriatrischer Beschwerden
Stephan Hepatitis‐Free Reagents in Tests for Australia Antigen
Hennessy et al. Effect of AlPO4 on antibody response